Alaska Permanent Fund Corp Buys New Position in UnitedHealth Group Incorporated (NYSE:UNH)

Alaska Permanent Fund Corp bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 8,058 shares of the healthcare conglomerate’s stock, valued at approximately $4,242,000.

Several other large investors have also added to or reduced their stakes in the company. Bray Capital Advisors raised its stake in UnitedHealth Group by 0.5% during the third quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock valued at $4,848,000 after purchasing an additional 50 shares in the last quarter. Trust Co. of Oklahoma bought a new position in shares of UnitedHealth Group in the third quarter worth about $441,000. Kraft Davis & Associates LLC lifted its position in shares of UnitedHealth Group by 3.4% during the third quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock valued at $294,000 after buying an additional 19 shares during the last quarter. Naples Global Advisors LLC lifted its position in shares of UnitedHealth Group by 0.8% during the third quarter. Naples Global Advisors LLC now owns 12,445 shares of the healthcare conglomerate’s stock valued at $6,274,000 after buying an additional 98 shares during the last quarter. Finally, Bluesphere Advisors LLC raised its position in shares of UnitedHealth Group by 10.9% in the 3rd quarter. Bluesphere Advisors LLC now owns 2,614 shares of the healthcare conglomerate’s stock valued at $1,318,000 after purchasing an additional 256 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded up $1.12 during trading hours on Wednesday, reaching $487.30. The stock had a trading volume of 3,722,294 shares, compared to its average volume of 4,532,979. The firm has a 50-day moving average of $487.49 and a 200-day moving average of $514.76. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The firm has a market cap of $449.26 billion, a price-to-earnings ratio of 29.48, a PEG ratio of 1.42 and a beta of 0.54. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s revenue was up 8.6% compared to the same quarter last year. During the same period in the prior year, the business earned $6.26 EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a yield of 1.54%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

Insider Buying and Selling at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. Truist Financial reaffirmed a “buy” rating and issued a $600.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Bank of America reiterated a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Oppenheimer reiterated an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a report on Wednesday, January 17th. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. Finally, Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Four analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $570.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.